Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI034301-03
Application #
2069406
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
1993-07-01
Project End
1997-06-30
Budget Start
1995-07-01
Budget End
1997-06-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost

  Institution

Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213

  Publications

Shi, C; Mellors, J W (1997) A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors. Antimicrob Agents Chemother 41:2781-5
Mellors, J W; Rinaldo Jr, C R; Gupta, P et al. (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-70
Medina, D J; Tung, P P; Sathya, B et al. (1996) Use of floxuridine to modulate the antiviral activity of zidovudine. AIDS Res Hum Retroviruses 12:965-8
Mellors, J W; Kingsley, L A; Rinaldo Jr, C R et al. (1995) Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122:573-9
Gupta, P; Ding, M; Cottrill, M et al. (1995) Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay. J Clin Microbiol 33:1670-3
Mellors, J W; Bazmi, H Z; Schinazi, R F et al. (1995) Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates. Antimicrob Agents Chemother 39:1087-92